Factors associated with not receiving HPV vaccine among adolescents by metropolitan statistical area status, United States, National Immunization Survey-Teen, 2016-2017

Charnetta L Williams, Tanja Y Walker, Laurie D Elam-Evans, David Yankey, Benjamin Fredua, Mona Saraiya, Shannon Stokley, Charnetta L Williams, Tanja Y Walker, Laurie D Elam-Evans, David Yankey, Benjamin Fredua, Mona Saraiya, Shannon Stokley

Abstract

The 2016 and 2017 National Immunization Surveys-Teen (NIS-Teen) highlighted disparities in human papillomavirus (HPV) vaccination coverage by metropolitan statistical area (MSA) status. Coverage with ≥1 dose of HPV vaccine was significantly lower among teens in suburban and mostly rural areas than it was among those in mostly urban areas. Reasons underlying this disparity are poorly understood; this analysis sought to identify sociodemographic factors associated with not initiating the HPV vaccine series and to determine whether these factors differed by MSA status. Using NIS-Teen data for a sample of 41,424 adolescents from the 2016 and 2017 survey years, multivariate logistic regression was utilized to assess associations between various sociodemographic factors and non-initiation of the HPV vaccine series by MSA status. Adjusted prevalence ratios and 95% confidence intervals are reported. A secondary analysis assessed missed opportunities for HPV vaccination by MSA status and estimated what coverage could be if these missed opportunities had not occurred. Most factors associated with not receiving HPV vaccine were similar across all three MSAs, including living in the South, having a mother with some college education, not having an 11-12-year-old well-child visit, and not receiving a provider recommendation for vaccination. Others were associated with non-initiation of the HPV vaccine series in only specific MSAs. Teens in suburban areas (82.2%) were more likely to miss opportunities for HPV vaccination than those in mostly urban (79.3%) areas. Coverage with ≥1 dose of HPV vaccine in all three MSAs would be substantially higher if these missed opportunities had been eliminated.

Keywords: Human papillomavirus (HPV); adolescents; disparity; rural; sociodemographic factors; urban.

Figures

Figure 1.
Figure 1.
Actual and potentially achievable vaccination coverage with ≥1 dose of human papillomavirus (HPV) vaccine if missed opportunities* for vaccination had been eliminated among teens by age 13 years, – National Immunization Survey-Teen, United States, 2016–2017, N = 41,424.

References

    1. Robinson CL, Romero JR, Kempe A, Pellegrini C, Szilagyi P.. Advisory committee on immunization practices recommended immunization schedule for children and adolescents aged 18 years or younger - United States, 2018. MMWR Morb Mortal Wkly Rep. 2018;67(5):156–57. doi:10.15585/mmwr.mm6705e2.
    1. Merck Sharp & Dohme Corp . Package insert -Gardasil 9-. Whitehouse Station (NJ): MERCK & CO., INC.; 2006–2018.
    1. Centers for Disease Control and Prevention . Cancers Associated with Human Papillomavirus, United States—2011–2015 USCS Data Brief, No. 4. Atlanta (GA): Centers for Disease Control and Prevention; 2018.
    1. Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Mbaeyi SA, Fredua B, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(33):909–17. doi:10.15585/mmwr.mm6733a1.
    1. Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(33):874–82. doi:10.15585/mmwr.mm6633a2.
    1. Zahnd WE, James AS, Jenkins WD, Izadi SR, Fogleman AJ, Steward DE, Colditz GA, Brard L. Rural-urban differences in cancer incidence and trends in the United States. Cancer Epidemiol Biomarkers Prev. 2017;27(11):1–10.
    1. Yu L, Sabatino SA, White MC. Rural-urban and racial/ethnic disparities in invasive cervical cancer incidence in the United States, 2010-2014. Prev Chronic Dis. 2019;16:E70. doi:10.5888/pcd16.180447.
    1. Curtis CR, Dorell C, Yankey D, Jeyarajah J, Chesson H, Saraiya M, Gold R, Dunne EF, Stokley S. National human papillomavirus vaccination coverage among adolescents aged 13-17 years-National Immunization Survey–Teen, United States, 2011. MMWR Suppl. 2014;63:61–70.
    1. Henry KA, Stroup AM, Warner EL, Kepka D. Geographic factors and human papillomavirus (HPV) vaccination initiation among adolescent girls in the United States. Cancer Epidemiol Biomarkers Prev. 2016;25(2):309–17. doi:10.1158/1055-9965.EPI-15-0658.
    1. Henry KA, Swiecki-Sikora AL, Stroup AM, Warner EL, Kepka D. Area-based socioeconomic factors and human papillomavirus (HPV) vaccination among teen boys in the United States. BMC Public Health. 2017;18(1):19. doi:10.1186/s12889-017-4567-2.
    1. Moss JL, Gilkey MB, Rimer BK, Brewer NT. Disparities in collaborative patient-provider communication about human papillomavirus (HPV) vaccination. Hum Vaccin Immunother. 2016;12(6):1476–83. doi:10.1080/21645515.2015.1128601.
    1. Mohammed KA, Subramaniam DS, Geneus CJ, Henderson ER, Dean CA, Subramaniam DP, Burroughs TE. Rural-urban differences in human papillomavirus knowledge and awareness among US adults. Prev Med. 2018;109:39–43. doi:10.1016/j.ypmed.2018.01.016.
    1. Wong CA, Taylor JA, Wright JA, Opel DJ, Katzenellenbogen RA. Missed opportunities for adolescent vaccination, 2006-2011. J Adolesc Health. 2013;53(4):492–97. doi:10.1016/j.jadohealth.2013.05.009.
    1. Vanderpool RC, Dressler EV, Stradtman LR, Crosby RA. Fatalistic beliefs and completion of the HPV vaccination series among a sample of young Appalachian Kentucky women. J Rural Health. 2015;31(2):199–205. doi:10.1111/jrh.12102.
    1. Vanderpool RC, Huang B, Deng Y, Bear TM, Chen Q, Johnson MF, Paskett ED, Robertson LB, Young GS, Iachan R. Cancer-related beliefs and perceptions in Appalachia: findings from 3 states. J Rural Health. 2019;35(2):176–88. doi:10.1111/jrh.12359.
    1. Centers for Disease Control and Prevention . About the National Immunization Surveys (NIS). Atlanta (GA): Centers for Disease Control and Prevention; 2018.
    1. Jain N, Singleton JA, Montgomery M, Skalland B. Determining accurate vaccination coverage rates for adolescents: the National Immunization Survey-Teen 2006. Public Health Rep. 2009;124(5):642–51. doi:10.1177/003335490912400506.
    1. Centers for Disease Control and Prevention . NIS-Teen Data and Documentation for 2015 to Present. Atlanta (GA): Centers for Disease Control and Prevention; 2018.
    1. Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30(24):3546–56. doi:10.1016/j.vaccine.2012.03.063.
    1. Lai D, Ding Q, Bodson J, Warner EL, Kepka D. Factors associated with increased HPV vaccine use in rural-frontier U.S. states. Public Health Nurs. 2016;33(4):283–94. doi:10.1111/phn.12223.
    1. Loke AY, Kwan ML, Wong YT, Wong AKY. The uptake of human papillomavirus vaccination and its associated factors among adolescents: a systematic review. J Prim Care Community Health. 2017;8(4):349–62. doi:10.1177/2150131917742299.
    1. Radisic G, Chapman J, Flight I, Wilson C. Factors associated with parents’ attitudes to the HPV vaccination of their adolescent sons: a systematic review. Prev Med. 2017;95:26–37. doi:10.1016/j.ypmed.2016.11.019.
    1. Mohammed KA, Vivian E, Loux TM, Arnold LD. Factors associated with parents’ intent to vaccinate adolescents for human papillomavirus: findings from the 2014 National Immunization Survey-Teen. Prev Chronic Dis. 2017;14:E45. doi:10.5888/pcd14.160314.
    1. Centers for Disease Control and Prevention . Vaccines for Children Program (VFC). Atlanta (GA): Centers for Disease Control and Prevention; 2018.
    1. United States Census Bureau . Current Population Survey Subject Definitions. United States Census Bureau; 2015.
    1. Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine. 2016;34(9):1187–92. doi:10.1016/j.vaccine.2016.01.023.
    1. Landis K, Bednarczyk RA, Gaydos LM. Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen. Vaccine. 2018;36(24):3498–504. doi:10.1016/j.vaccine.2018.04.075.
    1. Ylitalo KR, Lee H, Mehta NK. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health. 2013;103(1):164–69. doi:10.2105/AJPH.2011.300600.
    1. Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis RC, Markowitz L. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014–United States. MMWR Morb Mortal Wkly Rep. 2014;63:620–24.
    1. Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics. 2011;128(5):830–39. doi:10.1542/peds.2011-0950.
    1. Monnat SM, Rhubart DC, Wallington SF. Differences in human papillomavirus vaccination among adolescent girls in metropolitan versus non-metropolitan areas: considering the moderating roles of maternal socioeconomic status and health care access. Matern Child Health J. 2016;20(2):315–25. doi:10.1007/s10995-015-1831-x.
    1. Kester LM, Zimet GD, Fortenberry JD, Kahn JA, Shew ML. A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination. Matern Child Health J. 2013;17(5):879–85. doi:10.1007/s10995-012-1066-z.
    1. Warner EL, Ding Q, Pappas LM, Henry K, Kepka D. White, affluent, educated parents are least likely to choose HPV vaccination for their children: a cross-sectional study of the National Immunization Study - Teen. BMC Pediatr. 2017;17(1):200. doi:10.1186/s12887-017-0969-7.
    1. Shipman SA, Lan J, Chang CH, Goodman DC. Geographic maldistribution of primary care for children. Pediatrics. 2011;127(1):19–27. doi:10.1542/peds.2010-0150.
    1. Esposito S, Principi N, Cornaglia G; Group EVS . Barriers to the vaccination of children and adolescents and possible solutions. Clin Microbiol Infect. 2014;20(Suppl 5):25–31. doi:10.1111/1469-0691.12447.
    1. Lee GM, Lorick SA, Pfoh E, Kleinman K, Fishbein D. Adolescent immunizations: missed opportunities for prevention. Pediatrics. 2008;122(4):711–17. doi:10.1542/peds.2007-2857.
    1. Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017;139:1. doi:10.1542/peds.2016-1764.
    1. Dilley SE, Peral S, Straughn JM Jr., Scarinci IC. The challenge of HPV vaccination uptake and opportunities for solutions: lessons learned from Alabama. Prev Med. 2018;113:124–31. doi:10.1016/j.ypmed.2018.05.021.
    1. Boyd ED, Phillips JM, Schoenberger YM, Simpson T. Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers. Vaccine. 2018;36(28):4126–33. doi:10.1016/j.vaccine.2018.04.085.
    1. Cartmell KB, Young-Pierce J, McGue S, Alberg AJ, Luque JS, Zubizarreta M, Brandt HM. Barriers, facilitators, and potential strategies for increasing HPV vaccination: a statewide assessment to inform action. Papillomavirus Res. 2018;5:21–31. doi:10.1016/j.pvr.2017.11.003.
    1. Thomas T, Blumling A, Delaney A. The influence of religiosity and spirituality on rural parents’ health decision making and human papillomavirus vaccine choices. ANS Adv Nurs Sci. 2015;38(4):E1–E12. doi:10.1097/ANS.0000000000000094.
    1. Thomas TL, Strickland OL, DiClemente R, Higgins M, Haber M. Rural African American parents’ knowledge and decisions about human papillomavirus vaccination. J Nurs Scholarsh. 2012;44(4):358–67. doi:10.1111/j.1547-5069.2012.01479.x.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner